

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.20950027 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.25126007 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.25126007 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.01999136 |
| 5 | detection of other organism (GO:0098543) | 4.95708067 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.83880633 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.82045892 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.69405235 |
| 9 | leukocyte aggregation (GO:0070486) | 4.64938156 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 4.63839874 |
| 11 | detection of bacterium (GO:0016045) | 4.63124070 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.59740178 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.56596639 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 4.48500778 |
| 15 | detection of external biotic stimulus (GO:0098581) | 4.43939578 |
| 16 | negative regulation of cell killing (GO:0031342) | 4.41051894 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.41051894 |
| 18 | microglial cell activation (GO:0001774) | 4.23886920 |
| 19 | B cell receptor signaling pathway (GO:0050853) | 4.23523843 |
| 20 | regulation of B cell differentiation (GO:0045577) | 4.22611940 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.10033644 |
| 22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.02725742 |
| 23 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.00881842 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.93358881 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.93358881 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.93358881 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.93358881 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.93358881 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.93358881 |
| 30 | detection of biotic stimulus (GO:0009595) | 3.92944389 |
| 31 | macrophage activation (GO:0042116) | 3.87705414 |
| 32 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.79833853 |
| 33 | regulation of mast cell degranulation (GO:0043304) | 3.74749538 |
| 34 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74383799 |
| 35 | interferon-gamma production (GO:0032609) | 3.73146023 |
| 36 | neutrophil mediated immunity (GO:0002446) | 3.72799936 |
| 37 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.72457504 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.63284937 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.62036557 |
| 40 | cellular extravasation (GO:0045123) | 3.61653069 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.61371135 |
| 42 | negative regulation of phagocytosis (GO:0050765) | 3.60988462 |
| 43 | response to interleukin-15 (GO:0070672) | 3.59536565 |
| 44 | negative T cell selection (GO:0043383) | 3.58379980 |
| 45 | positive regulation of mast cell activation (GO:0033005) | 3.55682275 |
| 46 | positive T cell selection (GO:0043368) | 3.54104074 |
| 47 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.50639477 |
| 48 | tolerance induction (GO:0002507) | 3.49675191 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.46623769 |
| 50 | regulation of leukocyte degranulation (GO:0043300) | 3.45506995 |
| 51 | negative thymic T cell selection (GO:0045060) | 3.44103428 |
| 52 | T cell homeostasis (GO:0043029) | 3.39361510 |
| 53 | T cell migration (GO:0072678) | 3.38627108 |
| 54 | regulation of mast cell activation (GO:0033003) | 3.36284060 |
| 55 | lymphocyte homeostasis (GO:0002260) | 3.35261397 |
| 56 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.33739217 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.32778679 |
| 58 | B cell homeostasis (GO:0001782) | 3.31848745 |
| 59 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.30491862 |
| 60 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.28597331 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.26639776 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 3.26143382 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 3.25719281 |
| 64 | mature B cell differentiation (GO:0002335) | 3.23384597 |
| 65 | mast cell activation (GO:0045576) | 3.21509159 |
| 66 | immunoglobulin mediated immune response (GO:0016064) | 3.20690991 |
| 67 | thymic T cell selection (GO:0045061) | 3.19656761 |
| 68 | T cell selection (GO:0045058) | 3.18366315 |
| 69 | germinal center formation (GO:0002467) | 3.18147898 |
| 70 | neutrophil activation (GO:0042119) | 3.18102365 |
| 71 | cellular response to interleukin-15 (GO:0071350) | 3.16109654 |
| 72 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15629966 |
| 73 | macrophage activation involved in immune response (GO:0002281) | 3.15406844 |
| 74 | leukocyte degranulation (GO:0043299) | 3.13777726 |
| 75 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.11097761 |
| 76 | positive regulation of mast cell degranulation (GO:0043306) | 3.11097761 |
| 77 | response to muramyl dipeptide (GO:0032495) | 3.10726264 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 3.10667507 |
| 79 | regulation of tolerance induction (GO:0002643) | 3.10611272 |
| 80 | leukocyte cell-cell adhesion (GO:0007159) | 3.10316417 |
| 81 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.10225209 |
| 82 | positive regulation of granulocyte differentiation (GO:0030854) | 3.04335796 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03369768 |
| 84 | negative regulation of interleukin-6 production (GO:0032715) | 3.03142471 |
| 85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.03140523 |
| 86 | regulation of T cell tolerance induction (GO:0002664) | 3.01711737 |
| 87 | leukocyte homeostasis (GO:0001776) | 3.01175980 |
| 88 | negative regulation of granulocyte differentiation (GO:0030853) | 3.00464456 |
| 89 | T cell receptor signaling pathway (GO:0050852) | 2.99661151 |
| 90 | regulation of regulated secretory pathway (GO:1903305) | 2.99525937 |
| 91 | granulocyte activation (GO:0036230) | 2.94837468 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94595109 |
| 93 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.92645082 |
| 94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92531914 |
| 95 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91769657 |
| 96 | myeloid leukocyte activation (GO:0002274) | 2.90530601 |
| 97 | B cell mediated immunity (GO:0019724) | 2.90491887 |
| 98 | respiratory burst (GO:0045730) | 2.89797527 |
| 99 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.88682393 |
| 100 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88350021 |
| 101 | myeloid dendritic cell activation (GO:0001773) | 2.87619529 |
| 102 | negative regulation of type 2 immune response (GO:0002829) | 2.87474825 |
| 103 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.86778172 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.86650951 |
| 105 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85943762 |
| 106 | NIK/NF-kappaB signaling (GO:0038061) | 2.85900117 |
| 107 | neutrophil chemotaxis (GO:0030593) | 2.85760495 |
| 108 | dendritic cell migration (GO:0036336) | 2.84921573 |
| 109 | response to protozoan (GO:0001562) | 2.84446976 |
| 110 | response to peptidoglycan (GO:0032494) | 2.83767567 |
| 111 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.83327669 |
| 112 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82963516 |
| 113 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82963516 |
| 114 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.81561175 |
| 115 | definitive hemopoiesis (GO:0060216) | 2.80980938 |
| 116 | defense response to protozoan (GO:0042832) | 2.77890517 |
| 117 | positive regulation of interleukin-2 production (GO:0032743) | 2.77595583 |
| 118 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.77581579 |
| 119 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.76791958 |
| 120 | positive regulation of interferon-alpha production (GO:0032727) | 2.75069978 |
| 121 | regulation of granulocyte differentiation (GO:0030852) | 2.74126637 |
| 122 | response to type I interferon (GO:0034340) | 2.71564570 |
| 123 | B cell proliferation (GO:0042100) | 2.71173258 |
| 124 | lymph node development (GO:0048535) | 2.70840532 |
| 125 | natural killer cell differentiation (GO:0001779) | 2.70614091 |
| 126 | response to host immune response (GO:0052572) | 2.70135583 |
| 127 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70135583 |
| 128 | activated T cell proliferation (GO:0050798) | 2.67475963 |
| 129 | positive regulation of histone deacetylation (GO:0031065) | 2.64227438 |
| 130 | natural killer cell activation (GO:0030101) | 2.63951751 |
| 131 | regulation of interferon-alpha production (GO:0032647) | 2.62467520 |
| 132 | type I interferon signaling pathway (GO:0060337) | 2.62009684 |
| 133 | cellular response to type I interferon (GO:0071357) | 2.62009684 |
| 134 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60694539 |
| 135 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.60502440 |
| 136 | response to host defenses (GO:0052200) | 2.60363603 |
| 137 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60363603 |
| 138 | response to host (GO:0075136) | 2.60363603 |
| 139 | T cell costimulation (GO:0031295) | 2.59926932 |
| 140 | myeloid dendritic cell differentiation (GO:0043011) | 2.59600683 |
| 141 | mature B cell differentiation involved in immune response (GO:0002313) | 2.59435574 |
| 142 | positive regulation of B cell activation (GO:0050871) | 2.59236452 |
| 143 | mast cell activation involved in immune response (GO:0002279) | 2.58525106 |
| 144 | mast cell degranulation (GO:0043303) | 2.58525106 |
| 145 | negative regulation of B cell proliferation (GO:0030889) | 2.57389436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.83758934 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60274959 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.51714096 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.27338705 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.87885052 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.69381554 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.49086937 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41330880 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.32215576 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.22525159 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.16029197 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02870305 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.94601190 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.91777596 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85135287 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.84364356 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.84226305 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.79061712 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78741387 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.74789568 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.66499866 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57044481 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51273399 |
| 24 | * MAF_26560356_Chip-Seq_TH1_Human | 2.44893609 |
| 25 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43658862 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 2.39205222 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37987276 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31661304 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.30346683 |
| 30 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.27676331 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.26751890 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24929223 |
| 33 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.22900237 |
| 34 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.16433734 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12730153 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.06605144 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02850535 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99853807 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84197484 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74670387 |
| 41 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73465676 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67017397 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66061368 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65697599 |
| 45 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65684616 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65472301 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62997891 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60246015 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57196904 |
| 50 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56978973 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55392799 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54898468 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.53142157 |
| 54 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52380485 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51099046 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48267238 |
| 57 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43545441 |
| 58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41725614 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36751055 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36323174 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34479293 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34172891 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31370625 |
| 64 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29995118 |
| 65 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29669522 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29522761 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28411833 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28007655 |
| 69 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.27215698 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25570447 |
| 71 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23077093 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21807450 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21746725 |
| 74 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21270791 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20808453 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16324886 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15098377 |
| 78 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13765435 |
| 79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09398931 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08340805 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06960000 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05777809 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03344292 |
| 84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02602489 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01707633 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00345517 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98900202 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96414457 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95223834 |
| 90 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.94682429 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94027581 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90027805 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89489661 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87728928 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86395601 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85669332 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84974155 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84329531 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84052159 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84028811 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84014664 |
| 102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.83679100 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83253967 |
| 104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83223460 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82367371 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82255068 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80770846 |
| 108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79806270 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78990431 |
| 110 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.77154425 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.75726836 |
| 112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75708663 |
| 113 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74990220 |
| 114 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74848129 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71950758 |
| 116 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.71716864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.59315104 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.18757613 |
| 3 | MP0001800_abnormal_humoral_immune | 3.13771090 |
| 4 | MP0000685_abnormal_immune_system | 3.06162372 |
| 5 | MP0005671_abnormal_response_to | 3.02571665 |
| 6 | MP0003436_decreased_susceptibility_to | 3.00217621 |
| 7 | MP0003303_peritoneal_inflammation | 2.91969536 |
| 8 | MP0005387_immune_system_phenotype | 2.91045651 |
| 9 | MP0001790_abnormal_immune_system | 2.91045651 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.86063073 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.75322633 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.70698406 |
| 13 | * MP0002723_abnormal_immune_serum | 2.62632593 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.57133208 |
| 15 | * MP0001819_abnormal_immune_cell | 2.54488736 |
| 16 | MP0009785_altered_susceptibility_to | 2.51841125 |
| 17 | * MP0002398_abnormal_bone_marrow | 2.48061473 |
| 18 | * MP0002419_abnormal_innate_immunity | 2.45549188 |
| 19 | MP0009278_abnormal_bone_marrow | 2.43712165 |
| 20 | * MP0005025_abnormal_response_to | 2.39963821 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.33143011 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 2.30891158 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.29207182 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.24039510 |
| 25 | * MP0000716_abnormal_immune_system | 2.22207007 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.10064565 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.09292676 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.09002720 |
| 29 | MP0001545_abnormal_hematopoietic_system | 2.09002720 |
| 30 | MP0008260_abnormal_autophagy | 2.07613475 |
| 31 | MP0002405_respiratory_system_inflammati | 2.06004863 |
| 32 | MP0003724_increased_susceptibility_to | 2.05085463 |
| 33 | MP0002722_abnormal_immune_system | 2.03022174 |
| 34 | MP0001853_heart_inflammation | 1.99792706 |
| 35 | MP0004947_skin_inflammation | 1.94095936 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.91840914 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.87329088 |
| 38 | * MP0002429_abnormal_blood_cell | 1.87035669 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.84895533 |
| 40 | MP0001873_stomach_inflammation | 1.83334698 |
| 41 | MP0002006_tumorigenesis | 1.82900602 |
| 42 | MP0005451_abnormal_body_composition | 1.77807870 |
| 43 | * MP0001845_abnormal_inflammatory_respons | 1.69514740 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.66211314 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.65284633 |
| 46 | MP0006082_CNS_inflammation | 1.61679017 |
| 47 | MP0004883_abnormal_blood_vessel | 1.57558352 |
| 48 | MP0002933_joint_inflammation | 1.56371382 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.49803060 |
| 50 | MP0004510_myositis | 1.49155158 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.42487093 |
| 52 | MP0003866_abnormal_defecation | 1.41492448 |
| 53 | MP0000490_abnormal_crypts_of | 1.40406223 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.38694273 |
| 55 | * MP0003828_pulmonary_edema | 1.34706677 |
| 56 | MP0000858_altered_metastatic_potential | 1.34232250 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.29502243 |
| 58 | MP0008469_abnormal_protein_level | 1.27200340 |
| 59 | MP0003690_abnormal_glial_cell | 1.23511937 |
| 60 | MP0005164_abnormal_response_to | 1.20188793 |
| 61 | MP0003448_altered_tumor_morphology | 1.19624956 |
| 62 | MP0000604_amyloidosis | 1.18405872 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.14699043 |
| 64 | MP0001851_eye_inflammation | 1.14625265 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.13895970 |
| 66 | MP0005310_abnormal_salivary_gland | 1.12248526 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.09231844 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.07595191 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.05727883 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.02721648 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.02147543 |
| 72 | MP0009764_decreased_sensitivity_to | 1.00194451 |
| 73 | MP0005076_abnormal_cell_differentiation | 1.00164768 |
| 74 | MP0010307_abnormal_tumor_latency | 0.99574579 |
| 75 | MP0002095_abnormal_skin_pigmentation | 0.92890566 |
| 76 | MP0008057_abnormal_DNA_replication | 0.91619435 |
| 77 | MP0002132_abnormal_respiratory_system | 0.90801969 |
| 78 | MP0009840_abnormal_foam_cell | 0.90123489 |
| 79 | MP0008004_abnormal_stomach_pH | 0.87877361 |
| 80 | MP0010094_abnormal_chromosome_stability | 0.87538109 |
| 81 | MP0005023_abnormal_wound_healing | 0.83201636 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.81746452 |
| 83 | MP0000343_altered_response_to | 0.79845930 |
| 84 | MP0003693_abnormal_embryo_hatching | 0.79459499 |
| 85 | MP0002928_abnormal_bile_duct | 0.77789006 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.77610983 |
| 87 | MP0004130_abnormal_muscle_cell | 0.77539021 |
| 88 | MP0003077_abnormal_cell_cycle | 0.76432073 |
| 89 | MP0003091_abnormal_cell_migration | 0.75958385 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.75443231 |
| 91 | MP0008007_abnormal_cellular_replicative | 0.74650432 |
| 92 | MP0009763_increased_sensitivity_to | 0.74640732 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.73626050 |
| 94 | MP0005390_skeleton_phenotype | 0.72464994 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.70761830 |
| 96 | MP0005166_decreased_susceptibility_to | 0.70038047 |
| 97 | MP0003795_abnormal_bone_structure | 0.69862928 |
| 98 | MP0000371_diluted_coat_color | 0.67266553 |
| 99 | MP0003329_amyloid_beta_deposits | 0.64919769 |
| 100 | MP0000609_abnormal_liver_physiology | 0.64291287 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.63153366 |
| 102 | MP0003279_aneurysm | 0.62340901 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.61246117 |
| 104 | MP0000249_abnormal_blood_vessel | 0.61069685 |
| 105 | MP0001958_emphysema | 0.60991016 |
| 106 | MP0004381_abnormal_hair_follicle | 0.60417244 |
| 107 | MP0001663_abnormal_digestive_system | 0.60233094 |
| 108 | MP0008874_decreased_physiological_sensi | 0.60082497 |
| 109 | MP0003045_fibrosis | 0.59746816 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.59312352 |
| 111 | MP0006054_spinal_hemorrhage | 0.58445277 |
| 112 | MP0003111_abnormal_nucleus_morphology | 0.58141028 |
| 113 | MP0000313_abnormal_cell_death | 0.57523714 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.56899321 |
| 115 | MP0001191_abnormal_skin_condition | 0.56402191 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56300619 |
| 117 | MP0003075_altered_response_to | 0.54761510 |
| 118 | MP0002009_preneoplasia | 0.52823285 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.51686458 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.51332244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.84131731 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.70793416 |
| 3 | Recurrent viral infections (HP:0004429) | 4.56450206 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.44871893 |
| 5 | * Recurrent fungal infections (HP:0002841) | 4.13751588 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.05259051 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.03108592 |
| 8 | Cellulitis (HP:0100658) | 4.01776158 |
| 9 | IgM deficiency (HP:0002850) | 3.96700700 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 3.94802533 |
| 11 | T lymphocytopenia (HP:0005403) | 3.93184294 |
| 12 | Chronic otitis media (HP:0000389) | 3.92190512 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.90426428 |
| 14 | Abnormality of T cell number (HP:0011839) | 3.73197525 |
| 15 | Myositis (HP:0100614) | 3.70449071 |
| 16 | Meningitis (HP:0001287) | 3.65921928 |
| 17 | Thyroiditis (HP:0100646) | 3.62169457 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.56599222 |
| 19 | Keratoconjunctivitis sicca (HP:0001097) | 3.56563641 |
| 20 | B lymphocytopenia (HP:0010976) | 3.53064064 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.53064064 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.47710546 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.34944229 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.33982877 |
| 25 | Keratoconjunctivitis (HP:0001096) | 3.31521593 |
| 26 | Abnormality of the fingertips (HP:0001211) | 3.31502210 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.26843497 |
| 28 | Abnormality of T cells (HP:0002843) | 3.24809233 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.19170978 |
| 30 | Stomatitis (HP:0010280) | 3.17959366 |
| 31 | Gastrointestinal inflammation (HP:0004386) | 3.14319169 |
| 32 | Eosinophilia (HP:0001880) | 3.13903943 |
| 33 | Pustule (HP:0200039) | 3.08407552 |
| 34 | Colitis (HP:0002583) | 3.05437424 |
| 35 | * Recurrent skin infections (HP:0001581) | 3.01308413 |
| 36 | Vasculitis (HP:0002633) | 3.00951073 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.98984821 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.98984821 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.98984821 |
| 40 | Lymphopenia (HP:0001888) | 2.96456549 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.95413004 |
| 42 | Obstructive lung disease (HP:0006536) | 2.95049367 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95049367 |
| 44 | Severe combined immunodeficiency (HP:0004430) | 2.91950953 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.91439244 |
| 46 | Amyloidosis (HP:0011034) | 2.90385636 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.90120197 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 2.87886339 |
| 49 | Leukocytosis (HP:0001974) | 2.87377862 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.85478088 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.84656408 |
| 52 | Papilloma (HP:0012740) | 2.84115813 |
| 53 | Verrucae (HP:0200043) | 2.84115813 |
| 54 | Osteomyelitis (HP:0002754) | 2.82714595 |
| 55 | Hypochromic anemia (HP:0001931) | 2.79286481 |
| 56 | Episodic fever (HP:0001954) | 2.75597773 |
| 57 | Granulocytopenia (HP:0001913) | 2.74973612 |
| 58 | Peritonitis (HP:0002586) | 2.73935133 |
| 59 | Combined immunodeficiency (HP:0005387) | 2.70891461 |
| 60 | Abnormality of eosinophils (HP:0001879) | 2.70697951 |
| 61 | Gastrointestinal stroma tumor (HP:0100723) | 2.69705179 |
| 62 | * Hemoptysis (HP:0002105) | 2.69493250 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.68837620 |
| 64 | IgG deficiency (HP:0004315) | 2.67757926 |
| 65 | Epistaxis (HP:0000421) | 2.65589775 |
| 66 | Chronic diarrhea (HP:0002028) | 2.63954616 |
| 67 | Nasal polyposis (HP:0100582) | 2.63781306 |
| 68 | Gingival bleeding (HP:0000225) | 2.60397085 |
| 69 | Periodontitis (HP:0000704) | 2.60185879 |
| 70 | Abnormal platelet function (HP:0011869) | 2.55816195 |
| 71 | Impaired platelet aggregation (HP:0003540) | 2.55816195 |
| 72 | Thrombocytosis (HP:0001894) | 2.55747253 |
| 73 | Petechiae (HP:0000967) | 2.55292500 |
| 74 | Gingivitis (HP:0000230) | 2.54133114 |
| 75 | Pulmonary embolism (HP:0002204) | 2.52476099 |
| 76 | Anorexia (HP:0002039) | 2.52160819 |
| 77 | Recurrent sinusitis (HP:0011108) | 2.52071271 |
| 78 | Increased IgE level (HP:0003212) | 2.49012420 |
| 79 | Orchitis (HP:0100796) | 2.46907866 |
| 80 | * Recurrent cutaneous fungal infections (HP:0011370) | 2.44970618 |
| 81 | * Chronic mucocutaneous candidiasis (HP:0002728) | 2.44970618 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.43825588 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.43479391 |
| 84 | Recurrent pneumonia (HP:0006532) | 2.42939863 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.42819236 |
| 86 | Hypoplasia of the thymus (HP:0000778) | 2.41867125 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.35261491 |
| 88 | Optic neuritis (HP:0100653) | 2.35261491 |
| 89 | Loss of speech (HP:0002371) | 2.33642012 |
| 90 | Dysostosis multiplex (HP:0000943) | 2.32206236 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 2.31501458 |
| 92 | Chronic sinusitis (HP:0011109) | 2.30620659 |
| 93 | Arterial thrombosis (HP:0004420) | 2.26354252 |
| 94 | Lymphoma (HP:0002665) | 2.25953421 |
| 95 | Recurrent lower respiratory tract infections (HP:0002783) | 2.25925275 |
| 96 | Encephalitis (HP:0002383) | 2.24202460 |
| 97 | Hematochezia (HP:0002573) | 2.22169016 |
| 98 | Microcytic anemia (HP:0001935) | 2.21883174 |
| 99 | Sepsis (HP:0100806) | 2.20895545 |
| 100 | Emphysema (HP:0002097) | 2.19236041 |
| 101 | Abnormality of the pleura (HP:0002103) | 2.16352600 |
| 102 | Purpura (HP:0000979) | 2.16254327 |
| 103 | Increased IgM level (HP:0003496) | 2.15116702 |
| 104 | Gangrene (HP:0100758) | 2.12544041 |
| 105 | Acute myeloid leukemia (HP:0004808) | 2.12439816 |
| 106 | Abnormality of the prostate (HP:0008775) | 2.11544534 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 2.11538131 |
| 108 | IgA deficiency (HP:0002720) | 2.08627433 |
| 109 | Pulmonary infiltrates (HP:0002113) | 2.08452228 |
| 110 | Systemic lupus erythematosus (HP:0002725) | 2.08173399 |
| 111 | Slow saccadic eye movements (HP:0000514) | 2.04227550 |
| 112 | Increased serum ferritin (HP:0003281) | 2.03731280 |
| 113 | Abnormal platelet volume (HP:0011876) | 2.02630594 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 2.02417312 |
| 115 | Glomerulopathy (HP:0100820) | 1.99600198 |
| 116 | Urticaria (HP:0001025) | 1.98052049 |
| 117 | Hepatosplenomegaly (HP:0001433) | 1.97660538 |
| 118 | * Skin ulcer (HP:0200042) | 1.95811966 |
| 119 | Vertigo (HP:0002321) | 1.95079044 |
| 120 | Restrictive lung disease (HP:0002091) | 1.95068011 |
| 121 | Chest pain (HP:0100749) | 1.94844614 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.94473305 |
| 123 | Viral hepatitis (HP:0006562) | 1.92649164 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.92164355 |
| 125 | Acne (HP:0001061) | 1.89663254 |
| 126 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88925040 |
| 127 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88925040 |
| 128 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88925040 |
| 129 | Prostate neoplasm (HP:0100787) | 1.87127649 |
| 130 | Leukopenia (HP:0001882) | 1.86923773 |
| 131 | Keratitis (HP:0000491) | 1.85446499 |
| 132 | Polyneuropathy (HP:0001271) | 1.85271640 |
| 133 | Menorrhagia (HP:0000132) | 1.84878030 |
| 134 | Entropion (HP:0000621) | 1.84693819 |
| 135 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83207673 |
| 136 | Abnormality of the pericardium (HP:0001697) | 1.81854872 |
| 137 | Increased density of long bones (HP:0006392) | 1.79132011 |
| 138 | Acute lymphatic leukemia (HP:0006721) | 1.79091679 |
| 139 | Bronchitis (HP:0012387) | 1.78318593 |
| 140 | Vacuolated lymphocytes (HP:0001922) | 1.78235173 |
| 141 | Myocardial infarction (HP:0001658) | 1.77205184 |
| 142 | Spinal cord lesions (HP:0100561) | 1.74735664 |
| 143 | Syringomyelia (HP:0003396) | 1.74735664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.75621580 |
| 2 | TXK | 2.99345326 |
| 3 | PRPF4B | 2.55320759 |
| 4 | MAP3K10 | 2.40409338 |
| 5 | STK10 | 2.38370681 |
| 6 | EEF2K | 2.28058673 |
| 7 | TGFBR2 | 2.26077104 |
| 8 | TYK2 | 2.24390791 |
| 9 | ZAP70 | 2.19093272 |
| 10 | IRAK4 | 2.18252351 |
| 11 | JAK3 | 2.15200877 |
| 12 | KIT | 2.14829574 |
| 13 | BTK | 2.14152276 |
| 14 | ITK | 2.05327737 |
| 15 | TEC | 2.03914467 |
| 16 | MAP3K14 | 1.96922596 |
| 17 | GRK6 | 1.94532709 |
| 18 | CDK12 | 1.93078846 |
| 19 | ERN1 | 1.92616330 |
| 20 | TBK1 | 1.85350527 |
| 21 | BLK | 1.84116141 |
| 22 | CSF1R | 1.78683128 |
| 23 | FGR | 1.73283084 |
| 24 | SYK | 1.71468919 |
| 25 | IKBKE | 1.64387674 |
| 26 | SIK2 | 1.63572547 |
| 27 | RIPK4 | 1.62603278 |
| 28 | HCK | 1.54273018 |
| 29 | MAP3K13 | 1.53704268 |
| 30 | JAK1 | 1.53627060 |
| 31 | CSK | 1.45959636 |
| 32 | FLT3 | 1.40126397 |
| 33 | FES | 1.38400946 |
| 34 | MAP2K3 | 1.38154360 |
| 35 | RPS6KA4 | 1.37483178 |
| 36 | TAOK3 | 1.36760492 |
| 37 | IKBKB | 1.36129536 |
| 38 | LCK | 1.36045393 |
| 39 | IRAK3 | 1.34755281 |
| 40 | NLK | 1.33203054 |
| 41 | MAP3K11 | 1.33128752 |
| 42 | CLK1 | 1.32751844 |
| 43 | MARK3 | 1.28718582 |
| 44 | FGFR3 | 1.28221427 |
| 45 | MAP3K1 | 1.27771692 |
| 46 | FGFR4 | 1.27324078 |
| 47 | PIM1 | 1.25615951 |
| 48 | EPHB1 | 1.25090714 |
| 49 | SIK3 | 1.25055065 |
| 50 | PKN2 | 1.16840812 |
| 51 | KSR2 | 1.16211150 |
| 52 | TRIB3 | 1.14293865 |
| 53 | LYN | 1.12175435 |
| 54 | LRRK2 | 1.04875765 |
| 55 | MAP3K6 | 0.95781354 |
| 56 | PIK3CG | 0.95657509 |
| 57 | CAMK1D | 0.93183674 |
| 58 | IRAK1 | 0.92501728 |
| 59 | TAOK2 | 0.90130718 |
| 60 | JAK2 | 0.86456735 |
| 61 | IRAK2 | 0.85255448 |
| 62 | MAP3K2 | 0.84580409 |
| 63 | CHUK | 0.84539344 |
| 64 | BRD4 | 0.84246911 |
| 65 | NEK2 | 0.83896462 |
| 66 | BMPR2 | 0.83445189 |
| 67 | STK4 | 0.81998490 |
| 68 | PDPK1 | 0.81412072 |
| 69 | CDK4 | 0.80071557 |
| 70 | SIK1 | 0.76050153 |
| 71 | HIPK2 | 0.74741925 |
| 72 | CDC42BPA | 0.74317803 |
| 73 | TRPM7 | 0.71350962 |
| 74 | MAPK7 | 0.69720919 |
| 75 | NME2 | 0.69430059 |
| 76 | PTK2B | 0.69257291 |
| 77 | SMG1 | 0.69193816 |
| 78 | MAPK4 | 0.68800414 |
| 79 | PTK6 | 0.65129621 |
| 80 | MAPK11 | 0.64959916 |
| 81 | CDK6 | 0.63403668 |
| 82 | CAMK1G | 0.63066343 |
| 83 | MAP3K7 | 0.62423539 |
| 84 | SGK3 | 0.62405686 |
| 85 | CAMKK2 | 0.61792221 |
| 86 | EPHA3 | 0.59451964 |
| 87 | GRK7 | 0.59076933 |
| 88 | FYN | 0.57124349 |
| 89 | PRKCQ | 0.56454814 |
| 90 | PRKCH | 0.54987525 |
| 91 | MAP3K5 | 0.54657443 |
| 92 | MAP2K6 | 0.53720030 |
| 93 | STK11 | 0.53160817 |
| 94 | MAP2K4 | 0.52952025 |
| 95 | RPS6KA6 | 0.52498383 |
| 96 | TNK2 | 0.52280592 |
| 97 | TESK2 | 0.50359398 |
| 98 | CDK9 | 0.50339267 |
| 99 | TAOK1 | 0.48797775 |
| 100 | RPS6KB2 | 0.48186748 |
| 101 | ALK | 0.47738837 |
| 102 | RET | 0.47686065 |
| 103 | MAPKAPK2 | 0.47665388 |
| 104 | ATR | 0.47192192 |
| 105 | SGK2 | 0.46420466 |
| 106 | NEK9 | 0.45844894 |
| 107 | CAMKK1 | 0.45282938 |
| 108 | RAF1 | 0.44854544 |
| 109 | RPS6KC1 | 0.42641206 |
| 110 | RPS6KL1 | 0.42641206 |
| 111 | PIM2 | 0.42345734 |
| 112 | MAP3K3 | 0.40989264 |
| 113 | MAPK12 | 0.40709219 |
| 114 | MATK | 0.40153099 |
| 115 | WNK1 | 0.40020206 |
| 116 | MAP3K8 | 0.38507599 |
| 117 | PDK1 | 0.37701839 |
| 118 | YES1 | 0.37658408 |
| 119 | MELK | 0.37443040 |
| 120 | STK38 | 0.37305805 |
| 121 | MARK2 | 0.36561030 |
| 122 | PDGFRB | 0.36558009 |
| 123 | KSR1 | 0.36316072 |
| 124 | PRKD2 | 0.35662091 |
| 125 | ABL1 | 0.35586649 |
| 126 | EGFR | 0.34086377 |
| 127 | DAPK2 | 0.34026294 |
| 128 | ADRBK2 | 0.34020503 |
| 129 | TTN | 0.34011601 |
| 130 | KDR | 0.33410414 |
| 131 | RPS6KA2 | 0.33154318 |
| 132 | CDK7 | 0.31158374 |
| 133 | NUAK1 | 0.30785354 |
| 134 | MAPK3 | 0.30137250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.86203126 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.87788932 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67938713 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66513583 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.50605156 |
| 6 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.25319772 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.22004471 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.12646956 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.11809548 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.04695110 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.00560394 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90645462 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.84364115 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75577610 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.73426999 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72832913 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.70936033 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70102396 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.67885327 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66346595 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61984254 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.58965445 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54907866 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.51990033 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49694243 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.46909182 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.42143579 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.42042779 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40280082 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40218865 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39053906 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38953453 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.38903507 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36867772 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30546760 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29098719 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28536740 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.28329456 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.28242677 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.25079774 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.24789161 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.18680070 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.16511732 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12814263 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 1.06285418 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.04627899 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01938256 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99834961 |
| 49 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99327883 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99127840 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98233109 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97917382 |
| 53 | Asthma_Homo sapiens_hsa05310 | 0.95483580 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.95181099 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94900291 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.93572975 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90746523 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89777169 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89105868 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88609734 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87509754 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87498705 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85238388 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82821445 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81726955 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 0.81367727 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80553814 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 0.80016029 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74389843 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73072013 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.72160994 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70860452 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69667870 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69538335 |
| 75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66852439 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.64800056 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63545190 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.63128481 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62469099 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61768685 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60869386 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60109792 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.59385434 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58415553 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.58289582 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.56509711 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54587920 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53018526 |
| 89 | Mismatch repair_Homo sapiens_hsa03430 | 0.51635614 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51274023 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51000633 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49356063 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47521062 |
| 94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.46967244 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46942664 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46196536 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44936590 |
| 98 | Cell cycle_Homo sapiens_hsa04110 | 0.44904434 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44575985 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.44545560 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43494361 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43319487 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43002618 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42645924 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42289134 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41580297 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40521608 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40103828 |
| 109 | Spliceosome_Homo sapiens_hsa03040 | 0.39833663 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39121092 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37452926 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37284351 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36842961 |
| 114 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.35150382 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34847609 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34770948 |
| 117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34492076 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.34379004 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34301315 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.32987775 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31397516 |

